Blog · corpus.blog/blogs/pfizer.com
pfizer.com
pfizer.com · uncategorised · not detected
- Posts on record
- 10
- First published
- 10 June 2026
- Last published
- 22 September 2026
- Feed
- www.pfizer.com/rss.xml
- Language
- not detected
- Category
- uncategorised
Is this your blog?
Claim it to see who cites you, get citation alerts, send webmentions for the people you link to, and download your archive as markdown.
42blogs citing
61 links from citing blogs
Most cited pages
Page
Blogs
4blogs
pfizer.com/news/press-release/press-release-detail/pfizer-enters-exclusive-licensing-agreement-3sbio
2blogs
1blogs
1blogs
1blogs
1blogs
Blogs citing this one
Blog
Links
Posts
Links and posts differ when one blog links here several times from a single post: that is counted once as a citing blog either way.
Recent posts
Final Report - India Cohort Analysis: A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Given in a Series of 3 Infant Doses and 1 Toddler Dose in Infants in India and Taiwanoriginal ↗
22 Sept 2026
A Phase 1/2 Randomized, Observer-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Varicella Zoster Virus in Healthy Individuals Substudy A Supplemental CSR – Final Phase 1 Analysisoriginal ↗
21 Sept 2026
14 Sept 2026
19 Aug 2026
13 Aug 2026
An Interventional, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rimegepant for Migraine Prevention in Chinese Participantsoriginal ↗
13 Aug 2026
A PHASE 1/2, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALSoriginal ↗
15 Jul 2026
An Interventional, Open-Label, Randomized, Multicenter, Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in The Neoadjuvant Settinoriginal ↗
26 Jun 2026
Final Report: A Phase 3, Randomized, Double- Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Pregnant Participants Living with HIV and Their Inforiginal ↗
10 Jun 2026
A Phase 4, Randomized, Double-Blind Placebo-Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Useoriginal ↗
10 Jun 2026
All 10 posts, by year
A source page reaches every post it holds, not only the newest fifteen.